PeptideStack
5.2kquestions
20kanswers
220users

How much peptide am I losing to dead space on a fixed-needle syringe?

Asked 27 Jun 2025Modified 10 months agoViewed 34k times
30

My setup is a refrigerator with a logger and a small work area I wipe down, nothing more.

I have worked this out and I would like someone to find the error, because I suspect there is one.

My working so far, for the record, is below, and I am fairly sure the error is in the unit conversion rather than the algebra.

Where is my error, and what is the correct working?

dead-space
dead-space

The volume trapped in the syringe hub and needle after the plunger bottoms out. It is small in absolute terms and large as a fraction of a small…

110 questions
insulin-syringe
insulin-syringe

U-100 and U-40 insulin syringes as measuring instruments. A U-100 syringe is graduated in insulin units where 100 units equals 1 mL, so one unit…

268 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
PC
askedpierce_count15k2827 Jun 2025

5 Answers

Accepted answer first, then by votes
66

Accepted answer

The switch to a low-dead-space syringe nearly doubles your usable vial, which is better than switching suppliers if you are looking for cost savings.

The complete rule: fix the syringe architecture first, and then the reconstitution volume becomes a free choice you can make on stability grounds rather than on economics.

Dead space by syringe type

ConfigurationDead volumeLoss at 5 mg/mLOver 20 draws
Fixed-needle insulin syringe3–5 µL15–25 µg0.3–0.5 mg
Low-dead-space, detachable<2 µL<10 µg<0.2 mg
Standard luer-lock + 30G35–60 µL175–300 µg3.5–6 mg
Luer-lock + 21G drawing needle70–100 µL350–500 µg7–10 mg

Put another way, corollary that follows immediately: changing needle gauge or length barely changes your losses.

The World Health Organisation guidance on injection equipment adopted the same high-versus-low dead-space distinction, using a low-dead-space threshold in the low single-digit microlitres.

One qualification: the dead space does not affect the dose accuracy if the hub was full of solution at the start of the draw.

The switch nearly doubles your vial, which is better than most other optimisations combined.

shareimprove this answerflag
DO
answered · acceptedDr_Malik_Osei37k385 Sept 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
73

Specifically, at 100 µL draws the dead-space penalty with a luer-lock is 84 per cent per draw — the cost is genuinely catastrophic.

Be sceptical of anything advertised as low dead space that retains a conventional plunger tip: if you can look into the fitting with the plunger fully forward and see an open conical void, that void is your dead space.

Low-dead-space syringe designs either have the needle bonded directly to the barrel — a fixed-needle syringe, which is the cheapest route — or add a moulded projection on the plunger tip that fills the luer cone.

If cost matters, this is the first thing to change, not the last.

shareimprove this answerflag
RC
answeredRP_C1885k15813 Aug 2025
8This should probably be in the site help pages rather than buried in an answer. – rota_site 41 days ago
7Good answer, but the confidence interval in the cited trial is wider than implied. – per_haugen 10 months ago
add a comment
48

More usefully, dead space is irreducible with a high-dead-space syringe, which is why the hardware matters more than any technique.

At 5 mg/mL that is 15 to 25 µg lost per draw on the insulin syringe and 175 to 500 µg on the luer-lock — which over ten draws is the difference between losing a rounding error and losing half a milligram.

Worth being precise here: configuration A — 1 mL luer-lock plus detachable needle, dead space 84 µL: each draw removes 100 + 84 = 184 µL. Draws available from 2,000 µL = 2000 / 184 = 10.87, so 10 full draws.

Published inter-laboratory comparisons of dead-space measurements on identical syringes show good agreement, suggesting the numbers are reliable.

Buy the right syringe — a fixed-needle insulin syringe is cheap and solves the problem.

edited 7 Sept 2025 by a_lindgren — tightened the wording; no substantive change

shareimprove this answerflag
AL
answereda_lindgren46k13825 Aug 2025
Good answer, but the confidence interval in the cited trial is wider than implied. – Dr_Bram_Verhoeven 9 months ago
add a comment
30

Worth being precise here: dead space is the volume trapped in the syringe hub and needle after the plunger bottoms out, and it is the reason your 10 mg vial yields only 9.5 mg of usable draws.

Dead space quantified: a fixed-needle insulin syringe holds roughly 3 to 5 µL in the hub and needle after the plunger bottoms out. A luer-lock syringe with a detachable needle holds 35 to 100 µL depending on the hub design.

The switch nearly doubles your vial, which is better than most other optimisations combined.

shareimprove this answerflag
FR
answeredfib4_reader35k3816 Sept 2025
23

To be exact about it, this is arithmetic, so let us do the arithmetic and see where the losses actually are.

The needle lumen volume is under a microlitre in a typical fine-gauge configuration, so the needle is not the problem.

If cost matters, this is the first thing to change, not the last.

shareimprove this answerflag
TA
answeredtess_amankwah48k3827 Sept 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.